InMode Ltd. (NASDAQ:INMD) Shares Sold by Swiss National Bank

Swiss National Bank trimmed its position in shares of InMode Ltd. (NASDAQ:INMD) by 8.2% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 137,300 shares of the healthcare company’s stock after selling 12,300 shares during the quarter. Swiss National Bank owned approximately 0.20% of InMode worth $2,293,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. Quarry LP grew its holdings in shares of InMode by 154.3% during the third quarter. Quarry LP now owns 3,781 shares of the healthcare company’s stock worth $64,000 after buying an additional 2,294 shares in the last quarter. SBI Securities Co. Ltd. purchased a new stake in InMode during the 4th quarter valued at about $87,000. Farther Finance Advisors LLC raised its holdings in InMode by 26.2% in the 4th quarter. Farther Finance Advisors LLC now owns 5,555 shares of the healthcare company’s stock valued at $93,000 after acquiring an additional 1,154 shares during the last quarter. National Bank of Canada FI raised its holdings in InMode by 6.2% in the 3rd quarter. National Bank of Canada FI now owns 9,985 shares of the healthcare company’s stock valued at $169,000 after acquiring an additional 579 shares during the last quarter. Finally, HighTower Advisors LLC purchased a new position in InMode in the 4th quarter worth approximately $180,000. 68.04% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the company. Barclays upped their price target on InMode from $26.00 to $29.00 and gave the company an “overweight” rating in a research report on Wednesday, February 5th. Needham & Company LLC reissued a “hold” rating on shares of InMode in a research note on Tuesday, February 4th. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $22.25.

InMode Stock Performance

INMD stock opened at $18.30 on Friday. InMode Ltd. has a one year low of $14.87 and a one year high of $21.92. The firm has a market cap of $1.27 billion, a PE ratio of 7.79 and a beta of 2.08. The firm’s 50 day moving average price is $18.30 and its 200-day moving average price is $17.75.

InMode Profile

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.